{"id":"W1977715013","doi":"10.1016/j.purol.2010.11.010","title":"Traitement du carcinome rénal métastatique","year":2011,"lang":"fr","type":"review","venue":"Progrès en Urologie","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Temsirolimus; Sunitinib; Sorafenib; Medicine; Bevacizumab; Everolimus; Oncology; Renal cell carcinoma; Internal medicine; Population; Targeted therapy; Discovery and development of mTOR inhibitors; Cancer; Chemotherapy; PI3K/AKT/mTOR pathway; Hepatocellular carcinoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003206631,0.0007242116,0.001509813,0.002188175,0.0002297804,0.0006522891,0.0004807239,0.000723908,0.002881688],"category_scores_gemma":[0.0008323241,0.0002691053,0.000617446,0.001475744,0.0003998688,0.0009170955,0.0003503746,0.001193746,0.0008575289],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005665932,"about_ca_system_score_gemma":0.0007444723,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001551957,"about_ca_topic_score_gemma":0.003257751,"domain_scores_codex":[0.9998769,0.0000258638,0.00002231018,0.00002743482,0.00003518658,0.00001243327],"domain_scores_gemma":[0.9997019,0.0001658239,0.00007051726,0.000007481321,0.00003455015,0.00001966486],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001247011,0.00006138228,0.0003504885,0.02142961,0.0001866106,0.0005663093,0.00003331077,0.0003991363,0.001886341,0.0006430024,0.0242052,0.9501139],"study_design_scores_gemma":[0.0001618571,0.0004705489,0.003661898,0.008102521,0.001024449,0.01050644,0.00007840328,0.0003696534,0.002210602,0.0007864565,0.9725805,0.00004662656],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001981768,0.9988723,0.0001112739,0.0002019552,0.0001225125,0.000003499714,0.00001132844,0.000005941979,0.0004729673],"genre_scores_gemma":[0.002358178,0.9962568,0.0002014958,0.0002712609,0.0002943565,0.000006372823,0.00003602512,0.000001834888,0.0005735623],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002881688,"threshold_uncertainty_score":0.009640157,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1062349129353821,"score_gpt":0.3317235450283949,"score_spread":0.2254886320930128,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}